DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival

被引：0
|
作者：
Christine Aaserød Pedersen
Maria Dung Cao
Thomas Fleischer
Morten B. Rye
Stian Knappskog
Hans Petter Eikesdal
Per Eystein Lønning
Jörg Tost
Vessela N. Kristensen
May-Britt Tessem
Guro F. Giskeødegård
Tone F. Bathen
机构：
[1] NTNU - Norwegian University of Science and Technology,Department of Circulation and Medical Imaging
[2] Østfold University College,Department of Nursing, Health and Laboratory Science
[3] Oslo University Hospital,Department of Cancer Genetics, Institute for Cancer Research
[4] Trondheim University Hospital,Clinic of Surgery, St. Olavs Hospital
[5] NTNU – Norwegian University of Science and Technology,Department of Clinical and Molecular Medicine
[6] Trondheim University Hospital,Clinic of Laboratory Medicine, St. Olavs Hospital
[7] NTNU – Norwegian University of Science and Technology,BioCore
[8] University of Bergen, Bioinformatics Core Facility
[9] Haukeland University Hospital,K.G. Jebsen Centre for Genome
[10] Université Paris Saclay,Directed Cancer Therapy, Department of Clinical Science
[11] Oslo University Hospital,Department of Oncology
[12] NTNU - Norwegian University of Science and Technology,Laboratory for Epigenetics and Environment, Centre National de Recherche en Génomique Humaine, CEA – Institut de Biologie François Jacob
[13] St. Olavs Hospital,Department of Medical Genetics, Institute of Clinical Medicine
[14] Trondheim University Hospital,K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health, and Nursing
来源：
Breast Cancer Research | / 24卷
关键词：
DNA methylation; Locally advanced breast cancer; Survival; Treatment response; Breast cancer; Neoadjuvant chemotherapy; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival
    Pedersen, Christine Aaserod
    Cao, Maria Dung
    Fleischer, Thomas
    Rye, Morten B.
    Knappskog, Stian
    Eikesdal, Hans Petter
    Lonning, Per Eystein
    Tost, Jorg
    Kristensen, Vessela N.
    Tessem, May-Britt
    Giskeodegard, Guro F.
    Bathen, Tone F.
    BREAST CANCER RESEARCH, 2022, 24 (01)
  • [2] Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients
    Avraham, Ayelet
    Uhlmann, Ronit
    Shperber, Aino
    Birnbaum, Miriam
    Sandbank, Judith
    Sella, Avishay
    Sukumar, Saraswati
    Evron, Ella
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (07) : E1166 - E1172
  • [3] DNA methylation markers of breast cancer response to anthracycline based neoadjuvant chemotherapy
    Sigin, V. O.
    Strelnikov, V. V.
    Litviakov, N. V.
    Simonova, O. A.
    Volodin, V.
    Slonimskaya, E. M.
    Tanas, A. S.
    Zaletaev, D. V.
    Kuznetsova, E. B.
    Tsyganov, M. M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer
    Hannemann, J
    Oosterkamp, HM
    Bosch, CAJ
    Velds, A
    Wessels, LFA
    Loo, C
    Rutgers, EJ
    Rodenhuis, S
    van de Vijver, MJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3331 - 3342
  • [5] Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer
    Woo, Jinsun
    Ryu, Jai Min
    Jung, Sung Mi
    Choi, Hee Jun
    Lee, Se Kyung
    Yu, Jonghan
    Lee, Jeong Eon
    Kim, Seok Won
    Nam, Seok Jin
    Chae, Byung Joo
    EJSO, 2021, 47 (02): : 232 - 239
  • [6] Aberrant DNA methylation status of DNA repair genes in breast cancer treated with neoadjuvant chemotherapy
    Watanabe, Yoshiyuki
    Maeda, Ichiro
    Oikawa, Ritsuko
    Wu, Wenwen
    Tsuchiya, Kyoko
    Miyoshi, Yasuo
    Itoh, Fumio
    Tsugawa, Ko-ichiro
    Ohta, Tomohiko
    GENES TO CELLS, 2013, 18 (12) : 1120 - 1130
  • [7] DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients
    Sharma, Gayatri
    Mirza, Sameer
    Parshad, Rajinder
    Gupta, Siddartha Datta
    Ralhan, Ranju
    TUMOR BIOLOGY, 2012, 33 (06) : 1837 - 1843
  • [8] Development of DNA methylation markers panels for neoadjuvant chemotherapy response prediction in triple-negative breast cancer
    Sigin, V. O.
    Kalinkin, A. I.
    Ignatova, E.
    Chesnokova, G.
    Vinogradov, I. Y.
    Vinogradov, I. I.
    Vinogradov, M. I.
    Strelnikov, V. V.
    Zaletaev, D. V.
    Tanas, A. S.
    ANNALS OF ONCOLOGY, 2020, 31 : S1225 - S1225
  • [9] DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer
    Vladimir O. Sigin
    Alexey I. Kalinkin
    Ekaterina B. Kuznetsova
    Olga A. Simonova
    Galina G. Chesnokova
    Nikolai V. Litviakov
    Elena M. Slonimskaya
    Matvey M. Tsyganov
    Marina K. Ibragimova
    Ilya V. Volodin
    Ilya I. Vinogradov
    Maksim I. Vinogradov
    Igor Y. Vinogradov
    Sergey I. Kutsev
    Vladimir V. Strelnikov
    Dmitry V. Zaletaev
    Alexander S. Tanas
    Scientific Reports, 10
  • [10] Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer
    Meyer, Braydon
    Clifton, Samuel
    Locke, Warwick
    Luu, Phuc-Loi
    Du, Qian
    Lam, Dilys
    Armstrong, Nicola J.
    Kumar, Beena
    Deng, Niantao
    Harvey, Kate
    Swarbrick, Alex
    Ganju, Vinod
    Clark, Susan J.
    Pidsley, Ruth
    Stirzaker, Clare
    CLINICAL EPIGENETICS, 2021, 13 (01)
12345